Literature DB >> 22229064

Laparoscopic surgical staging of early ovarian cancer.

Sarah Weber1, Christopher K McCann, David M Boruta, John O Schorge, Whitfield B Growdon.   

Abstract

Since its advent in the early 1990s, laparoscopic surgical staging for early ovarian cancer has been explored as an option with the potential to offer women equivalent cancer control and survival as provided by laparotomy but with the clear benefits of minimally invasive surgery. A limited but expanding body of literature suggests aggressive surgical staging can be performed with equivalent tissue assessment compared with laparotomy. Given the lack of randomized, controlled trials, the risks and benefits of such a procedure remain ambiguous. This review summarizes the current body of literature regarding the role of laparoscopy in upfront surgical staging of ovarian cancer. This review presents the history, rationale, and established benefits and risks of utilizing this approach in women who present with malignancy that appears confined to the ovary. Although retrospective data confirm the feasibility, safety, and efficacy of laparoscopic staging of early ovarian cancer, more prospective data will be required to confirm equivalent survival in a patient population that has the potential to be cured.

Entities:  

Keywords:  Cancer staging; Laparoscopic surgical staging; Minimally invasive surgery; Ovarian cancer

Year:  2011        PMID: 22229064      PMCID: PMC3250973     

Source DB:  PubMed          Journal:  Rev Obstet Gynecol        ISSN: 1941-2797


  52 in total

1.  Port site metastasis after laparoscopic staging of esophageal carcinoma.

Authors:  R K Freeman; M A Wait
Journal:  Ann Thorac Surg       Date:  2001-03       Impact factor: 4.330

2.  Laparoscopy versus laparotomy for the surgical management of apparent early stage ovarian cancer.

Authors:  Fabio Ghezzi; Antonella Cromi; Stefano Uccella; Valentino Bergamini; Silvia Tomera; Massimo Franchi; Pierfrancesco Bolis
Journal:  Gynecol Oncol       Date:  2007-01-31       Impact factor: 5.482

3.  Port-site metastasis after laparoscopic surgery for endometrial carcinoma: two case reports.

Authors:  A Sanjuán; S Hernández; J Pahisa; J R Ayuso; A Torné; S Martínez Román; J A Lejárcegui; J Ordi; J A Vanrell
Journal:  Gynecol Oncol       Date:  2005-02       Impact factor: 5.482

4.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

5.  [Evaluation of laparoscopic surgery in the early stage-malignant tumor of ovary with lower risk].

Authors:  Ke-qin Hua; Fu-min Jin; Huan Xu; Zhi-ling Zhu; Jin-fang Lin; You-ji Feng
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2005-01-19

6.  Laparoscopic management of stage I ovarian cancer. A case report.

Authors:  H Reich; F McGlynn; W Wilkie
Journal:  J Reprod Med       Date:  1990-06       Impact factor: 0.142

7.  Laparoscopic management of early ovarian and fallopian tube cancers: surgical and survival outcome.

Authors:  Farr R Nezhat; Mohammad Ezzati; Linus Chuang; Alireza A Shamshirsaz; Jamal Rahaman; Herb Gretz
Journal:  Am J Obstet Gynecol       Date:  2008-11-18       Impact factor: 8.661

8.  Staging laparotomy in early ovarian cancer.

Authors:  R C Young; D G Decker; J T Wharton; M S Piver; W F Sindelar; B K Edwards; J P Smith
Journal:  JAMA       Date:  1983-12-09       Impact factor: 56.272

9.  Laparoscopic treatment of early ovarian cancer: surgical and survival outcomes.

Authors:  Roberto Tozzi; Christhardt Köhler; Alfonso Ferrara; Achim Schneider
Journal:  Gynecol Oncol       Date:  2004-04       Impact factor: 5.482

10.  Laparoscopic removal of adnexal cysts: is it possible to decrease inadvertent intraoperative rupture rate?

Authors:  Noam Smorgick; Oshri Barel; Reuvit Halperin; David Schneider; Moty Pansky
Journal:  Am J Obstet Gynecol       Date:  2009-03       Impact factor: 8.661

View more
  6 in total

Review 1.  Is It the Time for Laparoscopic Management of Early-stage Ovarian Malignancies?

Authors:  Tanitra Tantitamit; Chyi-Long Lee
Journal:  Gynecol Minim Invasive Ther       Date:  2018-08-23

2.  Transferability of the early-stage ovarian malignancy (EOM) score: an external validation study that includes advanced-stage and metastatic ovarian cancer.

Authors:  Phichayut Phinyo; Jayanton Patumanond; Panprapha Saenrungmuaeng; Watcharin Chirdchim; Tanyong Pipanmekaporn; Apichat Tantraworasin; Theera Tongsong; Charuwan Tantipalakorn
Journal:  Arch Gynecol Obstet       Date:  2021-01-09       Impact factor: 2.344

3.  Investigating the performance and cost-effectiveness of the simple ultrasound-based rules compared to the risk of malignancy index in the diagnosis of ovarian cancer (SUBSONiC-study): protocol of a prospective multicenter cohort study in the Netherlands.

Authors:  Evelyne M J Meys; Iris J G Rutten; Roy F P M Kruitwagen; Brigitte F Slangen; Martin G M Bergmans; Helen J M M Mertens; Ernst Nolting; Dieuwke Boskamp; Regina G H Beets-Tan; Toon van Gorp
Journal:  BMC Cancer       Date:  2015-06-26       Impact factor: 4.430

4.  Comparison of the prognosis and recurrence of apparent early-stage ovarian tumors treated with laparoscopy and laparotomy: a meta-analysis of clinical studies.

Authors:  Ying Zhang; Shuying Fan; Yang Xiang; Hua Duan; Li Sun
Journal:  BMC Cancer       Date:  2015-08-26       Impact factor: 4.430

Review 5.  Laparoscopic fertility-sparing surgery for early stage ovarian cancer: a single-centre case series and systematic literature review.

Authors:  Antonella Cromi; Giorgio Bogani; Stefano Uccella; Jvan Casarin; Maurizio Serati; Fabio Ghezzi
Journal:  J Ovarian Res       Date:  2014-05-29       Impact factor: 4.234

6.  Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.

Authors:  E M J Meys; L S Jeelof; N M J Achten; B F M Slangen; S Lambrechts; R F P M Kruitwagen; T Van Gorp
Journal:  Ultrasound Obstet Gynecol       Date:  2017-06       Impact factor: 7.299

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.